Objectives -The study aimed to consider the value of nitrate prescriptions issued by general practices as an indicator of coronary heart disease and to compare this with the use of coronary heart disease registers. Design -The study was a cross sectional survey. A selfcompleted questionnaire was used by general practices to indicate an age and gender breakdown of the total practice population, the number of patients taking nitrates, and details of patients recorded on a coronary heart disease register.
Wakefield has a high mortality from coronary heart disease (CHD), with a standardised mortality ratio of 121. Purchasing district health authorities now face the task of demonstrating effectiveness in achieving the Health of the Nation targets by reducing morbidity and mortality from CHD. Health authorities also have the responsibility of ensuring that the services in their district match the demands of the prevalence of CHD. Deaths, however, are not a good measure of local services because of the very long lead time between health interventions and outcomes. This study sought an intermediate measure -angina -as an indicator of CHD morbidity. The prevalence of angina is difficult to estimate. Attempts have been made to do so using both questionnaires and resting exercise electrocardiograms. These are of restricted use, however, due to methodological limitations, expense, and to the fact that they are typically focused on middle aged men.' One study,2 using assessment methods similar to those noted above, examined angina in both men and women, but only those in the 40-59 years age group.
A more recent study3 assessed the prevalence of angina by examining prescriptions issued for nitrates from the prescription analysis and cost (PACT) information system. This seemed to be a valid way of estimating the prevalence of angina as nitrates are usually issued for the treatment of angina related to CHD and are seldom used to treat any disease other than angina. This study established that nitrates were 96% specific to angina. In particular, a positive benefit of this study was that it used routinely available data, which is less expensive than planned large scale surveys. The study limitation, however, was the finding of low sensitivity. Patients' records were used as the "gold standard", but when they were examined only 73% of those with angina had been correctly identified. This may have been an effect of several factors, such as the exclusion of some drugs commonly used to treat angina and the fact that the methodology is reliant upon patients' compliance in presenting the prescription to the pharmacists.
Given the limitations of the above study,3
the present study used information directly obtained from GPs' records, which were expected to provide more sensitive data and facilitate an alternative and repeatable method of assessing the prevalence ofangina. Importantly, as a complete age and sex breakdown of angina to note that patient compliance may be lower than actual repeat prescription use. Additionally, when using GP records to assess regular nitrate use, it must be remembered that some nitrates are cheaper for patients to purchase directly from pharmacists than obtain on prescriptions. Given the methodology used, this may have contributed to an underestimate of the prevalence. This effect is difficult to estimate, but unless prescribing practices changed, one would expect this to remain consistent within a population sample. If future studies using the same approach were conducted, therefore, the error should be in the same magnitude.
CHD registers generally reported higher numbers than those receiving nitrates. The reason for this could include the fact that CHD records are more accurate in indicating the prevalence of CHD. Alternatively, the higher CHD rates may be due to errors in record keeping, changes in medical status of the patient, and no clear standardisation of criteria for eligibility for a CHD register. As an illustration, some practices may have patients recorded on the register if a family history is positive, while other practices may not. Also of importance are the changes in the medical status ofpatients, with some patients remaining on the CHD register after successful surgery.
The criteria for inclusion on CHD registers need to be agreed if they are to be used as indicators of prevalence of the condition.
Most practices which participated in the study indicated that data on nitrate prescription is not difficult to access. If this were a component of the new band 2 health promotion arrangements it would complement data obtained from CHD registers and act as an indicator ofprescribing habits and practice policy.
The prevalence figures determined by this study are higher than those reported in Cannon's study in Nottingham,' in which a total all age population of 1.5% was prescribed nitrates. 
